GLP-1 drugs don’t just lower blood sugar — they also make dangerous artery plaques more stable by reducing inflammation and strengthening the plaque’s outer shell, which helps prevent heart attacks and strokes.

GLP-1 drugs shrink a layer of fat that surrounds the heart — this fat is linked to heart disease, and shrinking it may help protect the heart from damage.

GLP-1 receptor agonists reduce cardiovascular event rates independently of LDL cholesterol modulation, primarily through weight loss and improved metabolic health.

GLP-1 diabetes drugs help prevent heart attacks and strokes mainly by lowering blood sugar and helping people lose weight—not by lowering blood pressure or bad cholesterol.

For people with type 2 diabetes, GLP-1 drugs like semaglutide and dulaglutide lower the chance of having a stroke caused by a blood clot by nearly 1 in 6 — more than any other diabetes medicine.

Diabetes drugs like semaglutide and liraglutide cut heart attacks, strokes, and kidney failure by up to a third — and they work fast, even before blood sugar drops, likely by calming down harmful inflammation in the body.